APOE epsilon 2
Selected indexed studies
- APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. (Neurology, 2004) [PMID:15210882]
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. (J Mol Med (Berl), 2016) [PMID:27277824]
- Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. (Age Ageing, 2008) [PMID:18250093]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. (2004) pubmed
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. (2016) pubmed
- Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. (2008) pubmed
- Protective ApoE variants support neuronal function by effluxing oxidized phospholipids. (2026) pubmed
- AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease mice. (2024) pubmed
- Apolipoprotein E-related glomerular disorders. (2020) pubmed
- The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D. (2017) pubmed
- APOE4 to APOE2 allelic switching in mice improves Alzheimer's disease-related metabolic signatures, neuropathology and cognition. (2025) pubmed
- Protective effect of apoE epsilon 2 in Alzheimer's disease. (1994) pubmed
- APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women. (2009) pubmed